On November 10, 2025, the 8th China International Import Expo, hosted by the Ministry of Commerce and the Shanghai Municipal Government, successfully concluded at the National Exhibition and Convention Center in Shanghai. As a Hong Kong-based innovative technology company, Eieling Technology showcased two groundbreaking achievements in the field of liver health: the Liverscan® Portable Liver Elastography Ultrasound Diagnostic System and the FattaLab® Fatty Liver Diagnostic Device. From underlying technology to application scenarios, the company comprehensively demonstrated its innovative strength in the field of non-invasive liver testing, attracting widespread attention from industry experts, government representatives, and patients with fatty liver disease at the event.
During the exhibition, John Lee, Chief Executive of the Hong Kong Special Administrative Region,and leaders from Shanghai and Nanjing visited the Eieling Technology booth and gave full recognition to the company’s innovative R&D achievements in recent years. They also encouraged the company to continue to leverage its own strengths, consolidate Hong Kong’s scientific research capabilities, and enhance its international appeal.
Hong Kong Chief Executive John Lee visits
Shanghai Vice Mayor Xie Dong led a delegation
Yao Hai, a member of the Standing Committee of the Shanghai Municipal Committee of the Chinese People’s Political Consultative Conference (CPPCC) and director of the Committee for Hong Kong, Macao, Taiwan and Overseas Chinese Affairs, led the delegation.
At the exhibition, the Yiling Technology booth was bustling with visitors. The team provided a comprehensive introduction to the product features and technological advantages of Liverscan® and FattaLab® through professional explanations and interactive demonstrations, attracting widespread attention and great interest from the attendees.
Wang Xiaohan, Deputy Minister of the United Front Work Department of the Shanghai Municipal Committee and Secretary of the Party Leadership Group of the Shanghai Federation of Industry and Commerce, led the team.
Wang Caiquan (first from left), member of the Standing Committee of the Jiangning District Committee of Nanjing City, and Jia Xiaojia (second from left), CEO of Eieling Technology.
Focusing on national strategies and sharing the benefits of development
The visiting leaders and experts pointed out from national strategic and policy perspectives that weight control and strengthening early prevention and control of liver disease have become important national public health issues, and early prevention can effectively reduce the overall prevalence of liver diseases. Against this backdrop, Eieling Technology’s products are considered to have broad development prospects. Liverscan®, with its portable design and patented technology, can quickly and accurately obtain quantitative data on liver stiffness and acoustic attenuation parameters within one minute, making it ideal for widespread use in primary healthcare institutions, hospitals, and clinics. and has become a powerful tool for clinical liver health assessment. Empowered by AI technology, Liverscan® further simplifies the operation process, effectively improving the work efficiency of medical personnel.
FattaLab® has pioneered a new path for convenient and lightweight testing of fatty liver disease. By actively responding to the National Health Commission’s “Weight Management Year” initiative, it helps in the early detection and intervention of fatty liver disease, contributing to reducing its prevalence in my country. Weighing only 120 grams, the device can complete the test and output quantitative data within 30 seconds, solving the pain points of traditional testing methods that are affected by operator skill and different body types, significantly lowering the barrier to entry. Its lightweight and easy-to-use design demonstrated stable and reliable performance during the exhibition demonstration. The collaborative display of Liverscan® and FattaLab® fully showcased Eieling Technology’s strong R&D capabilities and product innovation in the field of liver health management.
Connecting global opportunities, creating a healthy future together
At this year’s China International Import Expo (CIIE), Eieling Technology embraced an open approach, welcoming guests from around the world and actively collaborating with partners across various sectors to expand its network and protect the liver health of more patients. With a vast global population suffering from liver disease, early screening and effective intervention can reverse most cases, highlighting the paramount importance of early screening. Eieling Technology has already established a presence in medical institutions across Mainland China, Hong Kong, Macau, Southeast Asia, North America, South America, the Middle East, and Africa, contributing to the development of early liver disease prevention and control systems and earning widespread praise from local healthcare organizations.
Leveraging the China International Import Expo (CIIE), an international platform for dialogue, exchange, and cooperation, Eieling Technology engaged in in-depth discussions and forged partnerships with customers, partners, and industry experts from around the world, focusing on digital healthcare and liver health. Looking ahead, Eieling Technology will continue to deepen international collaborations, explore more innovative models, and jointly usher in a new chapter in liver disease prevention and treatment.